CCIR Experts Top Cardiologists

Thomas Drew

Thomas Drew, MD

Founder and Medical Director
Vice Chairman for Development, Rhode Island Hospital

Dr. Drew is a cardiologist with the Rhode Island Cardiology Center. His areas of expertise include adult congenital heart disease, invasive/interventional catheterization, and transfusion free medicine/surgery. In addition to his medical practice, Dr. Drew is a Clinical Associate Professor of Medicine at Brown University. He has been published nearly two dozen times in leading medical journals including the Journal of the American College of Cardiology, Circulation, and the American Heart Journal, amongst others and has been a featured speaker at medical conferences throughout the country for the past 25 years. Dr. Drew is a member of the Bristol Medical Association, the Rhode Island Medical Society, the American College of Physicians, and is a fellow of the American College of Cardiology.


Sheldon Goldberg

Sheldon Goldberg, MD

Founder
Professor and Director, Interventional Cardiovascular Medicine, MCP/Hahnemann University Hospital

Dr. Sheldon Goldberg is Professor of Medicine and Director of Interventional Cardiovascular Medicine at Hahnemann University Hospital. After receiving his undergraduate degree from New York University and his medical degree from the University of Pennsylvania, Dr. Goldberg completed graduate medical training in internal medicine and cardiovascular disease at Harvard University. He is an internationally recognized authority in interventional cardiology, and was the principal investigator of the landmark study published in the New England Journal of Medicine establishing the role of coronary artery stents in clinical practice. Dr. Goldberg has contributed numerous pivotal publications in the field of interventional cardiology. His current interests include new treatment modalities for patients with cardiovascular disease, including carotid intervention and therapy for structural heart disease. He is a leader of the PREVENT AMI Consortium, which is a multicenter group whose mission is to reduce the incidence of acute myocardial infarction and sudden cardiac death by screening, detecting and treating coronary plaques prone to future rupture.


Daniel McCormick

Daniel McCormick, DO

Founder
Director, Cardiovascular Interventional Therapy, Pennsylvania Hospital, University of Pennsylvania Health System

Dr. McCormick is nationally recognized as a leader in the development of catheter-based minimally invasive treatments for patients with cardiac, carotid and peripheral vascular disease. He is actively engaged in the medical training of both new and established physicians and is a pioneer in the development of Simulation and Internet-Based Online Medical Training Programs. Dr. McCormick is also at the forefront in the development of new technologies for advanced catheter-based therapies for peripheral and carotid vascular disease and structural heart disease including ASD/PFO closure, VSD closure, left atrial appendage occlusion, and mitral valve repair. He has been the Principal Investigator of more than 25 clinical trials involving cardiac pacemakers, defibrillators, angioplasty for acute myocardial infarction, coronary stenting, carotid stenting, and structural heart disease devices. He has participated in the premier, paradigm-shifting clinical trials that involved the first cardiac defibrillator, coronary drug- coated stent, and carotid stent.


Faculty


Heidar Arjomand

Heidar Arjomand, MD

Director, Endovascular Intervention, Seacoast Cardiology Associates

Dr. Arjomand graduated from Pecs University Medical School with Suma Cum Laude. He completed his training in General Cardiology and Interventional Cardiovascular Medicine at Hahnemann University Hospital in Philadelphia, Pennsylvania. He is currently the Director of Endovascular Intervention at Seacoast Cardiology Associates in the seacoast of New Hampshire. He has published multiple articles in peer reviewed journals. He has also authored and coauthored several book chapters. His area of clinical research interest includes coronary artery disease, antiplatelet therapy, and global vascular disease.


Firas Alani

Firas Alani, MD

Interventional Cardiologist, Covenant Heart Specialists

Dr. Firas Alani obtained his Cardiovascular, Interventional Cardiology, Endovascular Interventions and Structural Heart disease training at Hahnemann Hospital, Drexel University, in Philadelphia, PA. He is presently in private practice with Covenant Heart Specialists, Saginaw, MI and is the director of their Peripheral Vascular and Structural Heart Disease Program. Dr. Alani's clinical interests include complex coronary intervention, carotid artery disease and structural heart disease. He has presented more than 30 abstracts on these topics at various national conferences. He is active in clinical trials related to these fields and is a Principle Investigator on several National multi-canter Carotid Stenting trials and registries Dr. Alani is board certified by the American Board of Internal Medicine, American Board of Cardiovascular Medicine, American Board of Interventional Cardiology and American Board of Vascular Medicine. He is also a Fellow of the American College of Cardiology (ACC) and the Society of Cardiovascular Angiography and Interventions (SCAI).

[an error occurred while processing this directive]